2010
DOI: 10.1007/bf03195729
|View full text |Cite
|
Sign up to set email alerts
|

Charcot-Marie-Tooth type 1A disease caused by a novel Ser112Arg mutation in thePMP22 gene, coexisting with a slowly progressive hearing impairment

Abstract: Among 57 mutations in the peripheral myelin protein 22 gene (PMP22) identified so far in patients affected by Charcot-Marie-Tooth disease (CMT), only 8 have been shown to segregate with a mixed phenotype of CMT and hearing impairment. In this study, we report a new Ser112Arg mutation in the PMP22 gene, identified in a patient with early-onset CMT and slowly progressive hearing impairment beginning in the second decade of life. We suggest that the Ser112Arg mutation in the PMP22 gene might have a causative role… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…A fourth gene, Plp1 , is implicated in Spastic paraplegia-2 and Pelizaeus-Merzbacher diseases [51], which are disorders closely related to ataxia. It is also a homologue of Pmp22 , which is involved in Charcot Marie Tooth disease type 1A, a sensory neuropathy common in some forms of ataxia [52]. Thus, even in the case of less well-studied phenotypes or diseases, our tissue-specific approach is able to identify likely candidates as evidenced by our success rate of at least 40% for ataxia-related predictions based on the cerebellar network, compared to a background detection rate of less than 1/500.…”
Section: Resultsmentioning
confidence: 99%
“…A fourth gene, Plp1 , is implicated in Spastic paraplegia-2 and Pelizaeus-Merzbacher diseases [51], which are disorders closely related to ataxia. It is also a homologue of Pmp22 , which is involved in Charcot Marie Tooth disease type 1A, a sensory neuropathy common in some forms of ataxia [52]. Thus, even in the case of less well-studied phenotypes or diseases, our tissue-specific approach is able to identify likely candidates as evidenced by our success rate of at least 40% for ataxia-related predictions based on the cerebellar network, compared to a background detection rate of less than 1/500.…”
Section: Resultsmentioning
confidence: 99%
“…The auditory function deficits of CMT1A and CMT1E mice are profoundly different, but in each case are similar to those seen in patients with the respective mutations (3235, 3741, 68). Thus, we infer that it is likely that the cochlear structural phenotypes in each patient population correlate to those we see in each mouse model as well.…”
Section: Discussionmentioning
confidence: 70%
“…However, this has not been confirmed due to the lack of validated clinical HHL tests in humans (23,36). In contrast, patients with CMT1E, which is caused by a wide variety of PMP22 point mutations (29) and lead to more severe neuropathy phenotypes with earlier onset, suffer from overt hearing loss (elevated auditory thresholds) (37)(38)(39)(40)(41). Furthermore, a CMT1E mouse model, Trembler-J, has been shown to have profound deafness including AN fiber loss (42,43).…”
Section: Introductionmentioning
confidence: 99%